Company Filing History:
Years Active: 2023-2024
Title: Innovations by Sarah Jean Bethune
Introduction
Sarah Jean Bethune is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of aryl hydrocarbon receptor (AHR) inhibitors. With a total of 2 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
Bethune's latest patents include innovative formulations of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine. These compounds are designed to act as inhibitors of the AHR, which is implicated in various medical conditions. The first patent provides freebase and salt forms of this compound, while the second patent focuses on solid forms of the maleate variant, both aimed at enhancing therapeutic efficacy.
Career Highlights
Bethune is currently employed at Ikena Oncology, Inc., where she continues to innovate in the field of oncology. Her work is characterized by a commitment to developing effective treatments that target specific biological pathways.
Collaborations
Some of her notable coworkers include Alfredo C Castro and James Martin Nolan, III. Their collaborative efforts contribute to the advancement of research and development in their field.
Conclusion
Sarah Jean Bethune's contributions to the field of pharmaceuticals through her patents and work at Ikena Oncology, Inc. highlight her role as an influential inventor. Her innovative approaches to AHR inhibitors are set to make a significant impact in medical treatments.